- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASH Releases Analysis on Impact of Medicare Proposed Rules on Hematologists
On July 8, 2012, the Centers for Medicare & Medicaid Services (CMS) released two major Medicare proposed rules impacting payment for physician and hospital outpatient services in 2014. ASH will submit comments to CMS on the proposed rules by the September 6 deadline and would like to incorporate feedback from the Society's practice-based members.
On July 8, 2012, the Centers for Medicare & Medicaid Services (CMS) released two major Medicare proposed rules impacting payment for physician and hospital outpatient services in 2014. ASH will submit comments to CMS on the proposed rules by the September 6 deadline and would like to incorporate feedback from the Society's practice-based members. Review ASH's detailed analysis of the key issues and potential impact that the proposed rules will have on hematology and please contact ASH Government Relations and Practice Manager Stephanie Kaplan by August 16 with any comments you have about the proposed rule.
ASH Analysis of the Proposed Medicare Physician Fee Schedule (MPFS) CMS is proposing several changes to the physician fee schedule that will result in a net overall reduction in payment of 1 percent for hematology-oncology services. Modest changes are proposed for office-based evaluation and management (E/M) services while hospital visit and critical care codes will see increases of about 3 percent. Reductions are proposed for infusion codes, bone marrow biopsy and aspiration procedures. As in past years, the MPFS rule does not address the Sustainable Growth Rate formula driven payment reductions that will occur unless Congress takes action before the end of the year.
Read the full story here: http://bit.ly/17owDI6
Source: ASH
Infection Rate More Than Double in CLL/SLL Accompanied By Secondary Immunodeficiency Disease
December 19th 2024Secondary immunodeficiency disease (SID) status was associated with significantly higher risk for severe bacterial infections in adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Luspatercept Promising Against Anemia in MDS
December 18th 2024Findings from a phase 2 trial show that luspatercept effectively improves anemia in patients with lower-risk myelodysplastic syndromes (MDS), enabling them to delay or prevent transfusion dependence while maintaining a favorable safety profile.
Read More
Year-End Spending Bill to Feature Reforms for Pharmacy Benefit Managers and Telehealth Access
December 18th 2024The health care provisions include key reforms targeting pharmacy benefit managers, extensions of Medicare telehealth flexibilities, and measures aimed at combating the opioid crisis and preparing for future pandemics.
Read More
